Are cationic antimicrobial peptides also ‘double-edged swords’?

References

• Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol.3(3), 238–250 (2005).
   PubMed Web of Science ®Google Scholar
• Hale JD, Hancock RE. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev. Anti Infect. Ther.5(6), 951–959 (2007).
   PubMed Web of Science ®Google Scholar
• Fleming A. On the remarkable bacteriolytic element found in tissues and secretion. Proc. R. Soc. B(93), 303–317 (1922).
   Google Scholar
• Bichowsky-Slomnicki L, Berger A, Katchalski E, Kurtz J. The anti-bacterial action of some basic amino acid copolymers. Arch. Biochem. Biophys.65(1), 400–413 (1956).
   PubMed Web of Science ®Google Scholar
• Chertov O, Yang D, Howard OM, Oppenheim JJ. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol. Rev.177, 68–78 (2000).
   PubMed Web of Science ®Google Scholar
• Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J. Leukoc. Biol.64(1), 14–18 (1998).
   PubMed Web of Science ®Google Scholar
• Elsbach P, Weiss J. A reevaluation of the roles of the O2-dependent and O2-independent microbicidal systems of phagocytes. Rev. Infect. Dis.5(5), 843–853 (1983).
   PubMedGoogle Scholar
• Ganz T. Antimicrobial polypeptides in host defense of the respiratory tract. J. Clin. Invest.109(6), 693–697 (2002).
   PubMed Web of Science ®Google Scholar
• Ganz T, Lehrer RI. Antibiotic peptides from higher eukaryotes: biology and applications. Mol. Med. Today5(7), 292–297 (1999).
   PubMedGoogle Scholar
• Glynn AA. The complement lysozyme sequence in immune bacteriolysis. Immunology16(4), 463–471 (1969).
   PubMed Web of Science ®Google Scholar
• Hancock RE. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis.1(3), 156–164 (2001).
   PubMedGoogle Scholar
• Hancock RE, Scott MG. The role of antimicrobial peptides in animal defenses. Proc. Natl Acad. Sci. USA97(16), 8856–8861 (2000).
   PubMed Web of Science ®Google Scholar
• Hirsch JG. Bactericidal action of histone. J. Exp. Med.108(6), 925–944 (1958).
   PubMed Web of Science ®Google Scholar
• Lehrer RI, Ganz T. Cathelicidins: a family of endogenous antimicrobial peptides. Curr. Opin. Hematol.9(1), 18–22 (2002).
   PubMed Web of Science ®Google Scholar
• Levy O. A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein. Antimicrob. Agents Chemother.44(11), 2925–2931 (2000).
   PubMed Web of Science ®Google Scholar
• Levy O. Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood96(8), 2664–2672 (2000).
   PubMed Web of Science ®Google Scholar
• Odeberg H, Olsson I. Antibacterial activity of cationic proteins from human granulocytes. J. Clin. Invest.56(5), 1118–1124 (1975).
   PubMed Web of Science ®Google Scholar
• Otvos L Jr. Antibacterial peptides and proteins with multiple cellular targets. J. Pept. Sci.11(11), 697–706 (2005).
   PubMed Web of Science ®Google Scholar
• Risso A. Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity. J. Leukoc. Biol.68(6), 785–792 (2000).
   PubMed Web of Science ®Google Scholar
• Skarness RC, Watson DW. Anti-microbial factors of normal tissues and fluids. Bacteriol. Rev.21, 273–294 (1957).
   PubMedGoogle Scholar
• Yeaman MR, Bayer AS. Antimicrobial peptides from platelets. Drug Resist. Updat.2(2), 116–126 (1999).
   PubMed Web of Science ®Google Scholar
• Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev.55(1), 27–55 (2003).
   PubMed Web of Science ®Google Scholar
• Zasloff M. Antimicrobial peptides of multicellular organisms. Nature415(6870), 389–395 (2002).
   PubMed Web of Science ®Google Scholar
• Zeya HI, Spitznagel JK. Antibacterial and enzymic basic proteins from leukocyte lysosomes: separation and identification. Science142, 1085–1087 (1963).
   PubMed Web of Science ®Google Scholar
• Stolp H, Starr MP. Bacteriolysis. Annu. Rev. Microbiol.19, 79–104 (1965).
   PubMed Web of Science ®Google Scholar
• Ferne M, Duchan Z, Rabinowitz-Begner S, Sela MN, Ginsburg I. The effect of leukocyte hydrolases on bacteria. XII. The release of lipopolysaccharide (LPS) from Salmonella typhi by leukocyte extracts, lysozyme, inflammatory exudates and by serum and synovial fluid and the modulation by anionic and cationic polyelectrolytes of LPS release and the sensitization of erythrocytes. Inflammation3(1), 59–80 (1978).
   PubMedGoogle Scholar
• Ginsburg I. Cationic polyelectrolytes: a new look at their possible roles as opsonins, as stimulators of respiratory burst in leukocytes, in bacteriolysis, and as modulators of immune-complex diseases (a review hypothesis). Inflammation11(4), 489–515 (1987).
   PubMed Web of Science ®Google Scholar
• Ginsburg I. The biochemistry of bacteriolysis: paradoxes, facts and myths. Microbiol. Sci.5(5), 137–142 (1988).
   PubMedGoogle Scholar
• Ginsburg I. Cationic polyelectrolytes: potent opsonic agents which activate the respiratory burst in leukocytes. Free Radic. Res. Commun.8(1), 11–26 (1989).
   PubMed Web of Science ®Google Scholar
• Ginsburg I. Hypothesis: is a failure to prevent bacteriolysis and the synergy among microbial and host-derived pro-inflammatory agonists the main contributory factors to the pathogenesis of post-infectious sequelae? Inflammation25(1), 1–6 (2001).
   PubMed Web of Science ®Google Scholar
• Ginsburg I. Cationic peptides from leukocytes might kill bacteria by activating their autolytic enzymes causing bacteriolysis: why are publications proposing this concept never acknowledged? Blood97(8), 2530–2531 (2001).
   PubMed Web of Science ®Google Scholar
• Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect. Dis.2(3), 171–179 (2002).
   PubMed Web of Science ®Google Scholar
• Ginsburg I. The role of bacteriolysis in the pathophysiology of inflammation, infection and post-infectious sequelae. APMIS110(11), 753–770 (2002).
   PubMed Web of Science ®Google Scholar
• Ginsburg I. Bactericidal cationic peptides can also function as bacteriolysis-inducing agents mimicking β-lactam antibiotics?; it is enigmatic why this concept is consistently disregarded. Med. Hypotheses62(3), 367–374 (2004).
   PubMed Web of Science ®Google Scholar
• Ginsburg I, Lahav M. Lysis and biodegradation of microorganisms in infectious sites may involve cooperation between leukocyte, serum factors and bacterial wall autolysins: a working hypothesis. Eur. J. Clin. Microbiol.2(3), 186–191 (1983).
   PubMedGoogle Scholar
• Ginsburg I, Lahav M, Giesbrecht P. Effect of leukocyte hydrolases on bacteria. XVI. Activation by leukocyte factors and cationic substances of autolytic enzymes in Staphylococcus aureus: modulation by anionic polyelectrolytes in relation to survival of bacteria in inflammatory exudates. Inflammation6(3), 269–284 (1982).
   PubMed Web of Science ®Google Scholar
• Ginsburg I, Lahav M, Ne’eman N, Duchan Z, Chanes S, Sela MN. The interaction of leukocytes and their hydrolases with bacteria in vitro and in vivo: the modification of the bactericidal and bacteriolytic reactions by cationic and anionic macromolecular substances and by anti-inflammatory agents. Agents Actions6(1–3), 292–305 (1976).
   PubMedGoogle Scholar
• Lahav M, Ginsburg I. Effect of leukocyte hydrolases on bacteria. X. The role played by leukocyte factors, cationic polyelectrolytes, and by membrane-damaging agents in the lysis of Staphylococcus aureus: relation to chronic inflammatory processes. Inflammation2(2), 165–177 (1977).
   PubMedGoogle Scholar
• Lahav M, Ne’eman N, Adler E, Ginsburg I. Effect of leukocyte hydrolases on bacteria. 14C-labeled Streptococcus and Staphylococcus by leukocyte lysates in vitro.J. Infect. Dis.129(5), 528–537 (1974).
   PubMed Web of Science ®Google Scholar
• Neeman N, Lahav M, Ginsburg I. The effect of leukocyte hydrolases on bacteria. II. The synergistic action of lysozyme and extracts of PMN, macrophages, lymphocytes, and platelets in bacteriolysis. Proc. Soc. Exp. Biol. Med.146(4), 1137–1145 (1974).
   PubMed Web of Science ®Google Scholar
• Sela MN, Lahav M, Ginsburg I. Effect of leukocyte hydrolases on bacteria. IX. The release of lipoteichoic acid from group A streptococci and from Strep. mutants by leukocyte extracts and by lysozyme: relation to tissue damage in inflammatory sites. Inflammation2(2), 151–164 (1977).
   PubMedGoogle Scholar
• Wecke J, Lahav M, Ginsburg I, Giesbrecht P. Cell wall degradation of Staphylococcus aureus by lysozyme. Arch. Microbiol.131(2), 116–123 (1982).
   PubMed Web of Science ®Google Scholar
• Holtje JV. From growth to autolysis: the murein hydrolases in Escherichia coli.Arch. Microbiol.164(4), 243–254 (1995).
   PubMed Web of Science ®Google Scholar
• Vollmer W, Joris B, Charlier P, Foster S. Bacterial peptidoglycan (murein) hydrolases. FEMS Microbiol. Rev.32(2), 259–286 (2008).
   PubMed Web of Science ®Google Scholar
• Ginsburg I, Lahav M. How are bacterial cells degraded by leukocytes in vivo? An enigma. Clin. Immunol. Newsl.4(11), 147–153 (1983).
   Google Scholar
• Thorne KJ, Oliver RC, Barrett AJ. Lysis and killing of bacteria by lysosomal proteinases. Infect. Immun.14(2), 555–563 (1976).
   PubMed Web of Science ®Google Scholar
• Cottagnoud P, Tomasz A. Triggering of pneumococcal autolysis by lysozyme. J. Infect. Dis.167(3), 684–690 (1993).
   PubMed Web of Science ®Google Scholar
• Coonrod JD, Varble R, Yoneda K. Mechanism of killing of pneumococci by lysozyme. J. Infect. Dis.164(3), 527–532 (1991).
   PubMed Web of Science ®Google Scholar
• Laible NJ, Germaine GR. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides. Infect. Immun.48(3), 720–728 (1985).
   PubMed Web of Science ®Google Scholar
• Bierbaum G, Sahl HG. Influence of cationic peptides on the activity of the autolytic endo-β-N-acetylglucosaminidase of Staphylococcus simulans 22. FEMS Microbiol. Lett.49(2–3), 223–227 (1989).
   PubMed Web of Science ®Google Scholar
• Galvez A, Valdivia E, Martinez-Bueno M, Maqueda M. Induction of autolysis in Enterococcus faecalis S-47 by peptide AS-48. J. Appl. Bacteriol.69(3), 406–413 (1990).
   PubMedGoogle Scholar
• Sakagami Y, Mimura M, Kajimura K, Yokoyama H, Nishimura H. Electron-microscopic study of the bactericidal effect of OPB-2045, a new mono-biguanide disinfectant produced from biguanide group compounds, against Pseudomonas aeruginosa.J. Pharm. Pharmacol.51(2), 201–206 (1999).
   PubMed Web of Science ®Google Scholar
• Johansen L, Labischinski H, Burghaus P, Giesbrecht P. Acetylation in different phases of growth of staphylococci and their relation to cell wall degradability by lysozyme. In: The Target of Penicillin. Hakenbeck R, Holtje JV, Labischinski H (Eds). Walter de Gruyter, Berlin, Germany 261–266 (1983).
   Google Scholar
• Bera A, Biswas R, Herbert S et al. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J. Bacteriol.189(1), 280–283 (2007).
   PubMed Web of Science ®Google Scholar
• Herbert S, Bera A, Nerz C et al. Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog.3(7), e102 (2007).
   PubMed Web of Science ®Google Scholar
• Wecke J, Johannsen L, Giesbrecht P. Reduction of wall degradability of clindamycin-treated staphylococci within macrophages. Infect. Immun.58(1), 197–204 (1990).
   PubMed Web of Science ®Google Scholar
• Reinicke B, Blumel P, Giesbrecht P. Reduced degradability by lysozyme of staphylococcal cell walls after chloramphenicol treatment. Arch. Microbiol.135(2), 120–124 (1983).
   PubMed Web of Science ®Google Scholar
• Ganz T. Fatal attraction evaded. How pathogenic bacteria resist cationic polypeptides. J. Exp. Med.193(9), F31–F34 (2001).
   Google Scholar
• Xiong YQ, Yeaman MR, Bayer AS. in vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action. Antimicrob. Agents Chemother.43(5), 1111–1117 (1999).
   PubMed Web of Science ®Google Scholar
• Yeaman MR, Norman DC, Bayer AS. Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effect in Staphylococcus aureus.Antimicrob. Agents Chemother.36(8), 1665–1670 (1992).
   PubMed Web of Science ®Google Scholar
• Sahl HG, Pag U, Bonness S, Wagner S, Antcheva N, Tossi A. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol.77(4), 466–475 (2005).
   PubMed Web of Science ®Google Scholar
• Mani N, Tobin P, Jayaswal RK. Isolation and characterization of autolysis-defective mutants of Staphylococcus aureus created by Tn917-lacZ mutagenesis. J. Bacteriol.175(5), 1493–1499 (1993).
   PubMed Web of Science ®Google Scholar
• During K, Porsch P, Mahn A, Brinkmann O, Gieffers W. The non-enzymatic microbicidal activity of lysozymes. FEBS Lett.449(2–3), 93–100 (1999).
   PubMed Web of Science ®Google Scholar
• Ginsburg I. Role of leukocytes in infectious granulomatosis. In: Lysosomes in Applied Biology and Therapeutics. Dingle J, Jacques P, Shaw I (Eds). North Holland Publishing Company, Amsterdam, The Netherlands (19791979).
   Google Scholar
• Ginsburg I. Bacteriolysis is inhibited by hydrogen peroxide and by proteases. Agents Actions28(3–4), 238–242 (1989).
   PubMedGoogle Scholar
• Wecke J, Kwa E, Lahav M, Ginsburg I, Giesbrecht P. Suppression of penicillin-induced bacteriolysis of staphylococci by some anticoagulants. J. Antimicrob. Chemother.20(1), 47–55 (1987).
   PubMedGoogle Scholar
• Wecke J, Lahav M, Ginsburg I, Kwa E, Giesbrecht P. Inhibition of wall autolysis of staphylococci by sodium polyanethole sulfonate ‘liquoid’. Arch. Microbiol.144(2), 110–115 (1986).
   PubMed Web of Science ®Google Scholar
• Wecke J, Kersten T, Giesbrecht P. The modulation of the bacteriolytic effect of β-lactam antibiotics by non-antibiotics. APMIS30(Suppl.), 32–39 (1992).
   Google Scholar
• Rakita RM, Michel BR, Rosen H. Inactivation of Escherichia coli penicillin-binding proteins by human neutrophils. Infect. Immun.62(1), 162–165 (1994).
   PubMed Web of Science ®Google Scholar
• Wilson LA, Spitznagel JK. Molecular and structural damage to Escherichia coli produced by antibody, complement, and lysozyme systems. J. Bacteriol.96(4), 1339–1348 (1968).
   PubMed Web of Science ®Google Scholar
• Holzheimer RG. The significance of endotoxin release in experimental and clinical sepsis in surgical patients – evidence for antibiotic-induced endotoxin release? Infection26(2), 77–84 (1998).
   PubMed Web of Science ®Google Scholar
• Periti P, Mazzei T. Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review. J. Chemother.10(6), 427–448 (1998).
   PubMed Web of Science ®Google Scholar
• Shenep JL. Antibiotic-induced bacterial cell lysis: a therapeutic dilemma. Eur. J. Clin. Microbiol.5(1), 11–12 (1986).
   PubMedGoogle Scholar
• Shapiro DN, Varani J, Ginsburg I. Activation of a murine T-cell hybridoma by cationized bacteria. Immunology67(4), 478–483 (1989).
   PubMed Web of Science ®Google Scholar
• Horn DL, Opal SM, Lomastro E. Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in Gram-negative sepsis. Scand. J. Infect. Dis101(Suppl.), 9–13 (1996).
   Google Scholar
• Ginsburg I. Multi-drug strategies are necessary to inhibit the synergistic mechanism causing tissue damage and organ failure in post infectious sequelae. Inflammopharmacology7(3), 207–217 (1999).
   PubMedGoogle Scholar
• Marikovsky Y, Danon D, Katchalsky A. Agglutination by polylysine of young and old red blood cells. Biochim. Biophys. Acta.124(1), 154–159 (1966).
   PubMedGoogle Scholar
• Ginsburg I, Kohen R. Cell damage in inflammatory and infectious sites might involve a coordinated ‘cross-talk’ among oxidants, microbial haemolysins and ampiphiles, cationic proteins, phospholipases, fatty acids, proteinases and cytokines (an overview). Free Radic. Res.22(6), 489–517 (1995).
   PubMed Web of Science ®Google Scholar
• Ginsburg I, Fligiel SE, Kunkel RG, Riser BL, Varani J. Phagocytosis of Candida albicans enhances malignant behavior of murine tumor cells. Science238(4833), 1573–1575 (1987).
   PubMed Web of Science ®Google Scholar
• Brouwer CP, Wulferink M, Welling MM. The pharmacology of radiolabeled cationic antimicrobial peptides. J. Pharm. Sci.97(5), 1633–1651 (2007).
   Web of Science ®Google Scholar
• Parisien A, Allain B, Zhang J, Mandeville R, Lan CQ. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J. Appl. Microbiol.104(1), 1–13 (2008).
   PubMed Web of Science ®Google Scholar
• Lichtenstein AK, Ganz T, Selsted ME, Lehrer RI. Synergistic cytolysis mediated by hydrogen peroxide combined with peptide defensins. Cell. Immunol.114(1), 104–116 (1988).
   PubMed Web of Science ®Google Scholar
• Porro GA, Lee JH, de Azavedo J et al. Direct and indirect bacterial killing functions of neutrophil defensins in lung explants. Am. J. Physiol. Lung Cell. Mol. Physiol.281(5), L1240–L1247 (2001).
   Google Scholar
• Nagaoka I, Hirota S, Yomogida S, Ohwada A, Hirata M. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm. Res.49(2), 73–79 (2000).
   PubMed Web of Science ®Google Scholar
• Chen X, Niyonsaba F, Ushio H et al. Synergistic effect of antibacterial agents human β-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli.J. Dermatol. Sci.40(2), 123–132 (2005).
   PubMed Web of Science ®Google Scholar
• Bucki R, Namiot DB, Namiot Z, Savage PB, Janmey PA. Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. J. Antimicrob. Chemother. DOI: 10.1093/jac/dkn176 (2008) (Epub ahead of print).
   Google Scholar
• Dziarski R, Gupta D. Peptidoglycan recognition in innate immunity. J. Endotoxin Res.11(5), 304–310 (2005).
   PubMedGoogle Scholar
• Scott MG, Gold MR, Hancock RE. Interaction of cationic peptides with lipoteichoic acid and Gram-positive bacteria. Infect. Immun.67(12), 6445–6453 (1999).
   PubMed Web of Science ®Google Scholar
• Dishon T, Finkel R, Marcus Z, Ginsburg I. Cell-sensitizing products of streptococci. Immunology13(6), 555–564 (1967).
   PubMed Web of Science ®Google Scholar
• Zughaier SM, Shafer WM, Stephens DS. Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Cell. Microbiol.7(9), 1251–1262 (2005).
   PubMed Web of Science ®Google Scholar
• Barak V, Kalickman I, Halperin T, Birkenfeld S, Ginsburg I. PADMA-28, a Tibetan herbal preparation is an inhibitor of inflammatory cytokine production. Eur. Cytokine Netw.15(3), 203–209 (2004).
   PubMed Web of Science ®Google Scholar
• Singh PK, Tack BF, McCray PB Jr, Welsh MJ. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am. J. Physiol. Lung Cell. Mol. Physiol.279(5), L799–L805 (2000).
   PubMed Web of Science ®Google Scholar
• Bucki R, Levental I, Janmey P. Antibacterial peptides – a bright future or a false hope. Anti-Infective Agents Med. Chem.6(3), 175–184 (2007).
   Google Scholar
• Peschel A, Sahl HG. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol.4(7), 529–536 (2006).
   PubMed Web of Science ®Google Scholar
• Schwab JH, Cromartie WJ, Ohanian SH, Craddock JG. Association of experimental chronic arthritis with the persistence of group A streptococcal cell walls in the articular tissue. J. Bacteriol.94(5), 1728–1735 (1967).
   PubMed Web of Science ®Google Scholar
• Spanel R, Galle J, Heymer B, Haferkamp O, Schmidt WC. Induction of granulomatous hepatitis in mice infected with group A streptococci and treated with penicillin. Virchows Arch. A Pathol. Anat. Histol.363(4), 323–332 (1974).
   PubMed Web of Science ®Google Scholar
• Ginsburg I, Gallis HA, Cole RM. Group A streptococci: localization in rabbits and guinea pigs following tissue injury. Science166(909), 1161–1163 (1969).
   PubMed Web of Science ®Google Scholar
• Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell124(4), 783–801 (2006).
   PubMed Web of Science ®Google Scholar
• Stewart-Tull DES. The immunological activities of bacterial peptidoglycans. Ann. Rev. Microbiol.34, 311–340 (1980).
   PubMed Web of Science ®Google Scholar
• Oshimi K, Kano S, Takaku F, Okumura K. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432. J. Natl Cancer Inst.65(6), 1265–1269 (1980).
   PubMedGoogle Scholar
• Fujimoto T, Duda RB, Szilvasi A, Chen X, Mai M, O’Donnell MA. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state. J. Immunol.158(12), 5619–5626 (1997).
   PubMed Web of Science ®Google Scholar